Evidence map›Paper›PMID 30253067›Full record

ArticleCurrent protocols in immunology2019

Mouse Model for Human Vitiligo.

Rebecca L Riding, Jillian M Richmond, John E Harris

Open access · greenAbstract read
In one paragraph

Article in Current protocols in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Deciphering Depigmentation: Mouse Models for Vitiligo Research.The Journal of investigative dermatology · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Translational Research in Vitiligo.Frontiers in immunology · 2021
    Review
  19. Mouse Models of Alopecia Areata: C3H/HeJ Mice Versus the Humanized AA Mouse Model.The journal of investigative dermatology. Symposium proceedings · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rebecca L RidingDepartment of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.
Jillian M RichmondDepartment of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.
John E HarrisDepartment of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.
University of Massachusetts Chan Medical School · US

Funding

TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Treg Migration and Function During Autoimmunity within Peripheral TissueR01AR069114 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HARRIS, JOHN E · 2015 to 2020
$2.2M
Dissecting autoimmune cellular and molecular networks in vitiligoR61AR073042 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GARBER, MANUEL, HARRIS, JOHN E · 2017 to 2018
$838k
NIAID NIH HHS T32 AI007349NIAMS NIH HHS R01 AR069114NIAMS NIH HHS R61 AR073042
6 · The paper itself

Abstract

Vitiligo is an autoimmune skin disease in which the pigment-producing melanocytes are destroyed by autoreactive CD8

Indexed as

Disease Models, AnimalAnimalsCD8-Positive T-LymphocytesHumansMiceMice, TransgenicStem Cell FactorVitiligoStem Cell FactorautoimmunityCD8 T cellsmelanocytemicevitiligo

Identifiers

PMID30253067
PMCPMC6340773
OpenAlexW2893604676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.